NASDAQ:IMVT

Immunovant News Headlines

$11.24
+0.10 (+0.90 %)
(As of 06/18/2021 03:59 PM ET)
Add
Compare
Today's Range
$10.82
▼
$11.26
50-Day Range
$9.40
▼
$16.76
52-Week Range
$9.22
▼
$53.75
Volume38,536 shs
Average Volume1.42 million shs
Market Capitalization$1.10 billion
P/E RatioN/A
Dividend YieldN/A
Beta0.84

Immunovant (NASDAQ IMVT) News Headlines Today

SourceHeadline
Credit Suisse Group Increases Immunovant (NASDAQ:IMVT) Price Target to $26.00Credit Suisse Group Increases Immunovant (NASDAQ:IMVT) Price Target to $26.00
marketbeat.com - June 2 at 8:19 AM
3 Health Care Stocks That Could Double by Year End (IMVT)3 Health Care Stocks That Could Double by Year End (IMVT)
marketbeat.com - February 11 at 10:50 AM
Companies Like Immunovant (NASDAQ:IMVT) Are In A Position To Invest In Growth - Yahoo FinanceCompanies Like Immunovant (NASDAQ:IMVT) Are In A Position To Invest In Growth - Yahoo Finance
finance.yahoo.com - June 18 at 1:04 PM
Companies Like Immunovant (NASDAQ:IMVT) Are In A Position To Invest In GrowthCompanies Like Immunovant (NASDAQ:IMVT) Are In A Position To Invest In Growth
finance.yahoo.com - June 18 at 8:03 AM
Head-To-Head Review: Immunovant (NASDAQ:IMVT) vs. Cullinan Oncology (NASDAQ:CGEM)Head-To-Head Review: Immunovant (NASDAQ:IMVT) vs. Cullinan Oncology (NASDAQ:CGEM)
americanbankingnews.com - June 17 at 1:20 PM
Argenx Is a Biotech Stock With Big Potential - BarronsArgenx Is a Biotech Stock With Big Potential - Barron's
barrons.com - June 15 at 7:00 AM
Comparing Immunovant (NASDAQ:IMVT) & Outlook Therapeutics (NASDAQ:OTLK)Comparing Immunovant (NASDAQ:IMVT) & Outlook Therapeutics (NASDAQ:OTLK)
americanbankingnews.com - June 13 at 11:22 AM
Immunovant (NASDAQ:IMVT) Trading Down 4.9%Immunovant (NASDAQ:IMVT) Trading Down 4.9%
americanbankingnews.com - June 4 at 11:56 AM
Immunovant (NASDAQ:IMVT) Trading Up 4.9% on Analyst UpgradeImmunovant (NASDAQ:IMVT) Trading Up 4.9% on Analyst Upgrade
americanbankingnews.com - June 3 at 11:14 AM
SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Immunovant, Inc. (IMVT) and Encourages Stockholders to Contact the Firm - Yahoo FinanceSHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Immunovant, Inc. (IMVT) and Encourages Stockholders to Contact the Firm - Yahoo Finance
finance.yahoo.com - June 2 at 7:18 PM
Immunovant (IMVT) Reports Narrower-Than-Expected Loss in Q4 - Yahoo FinanceImmunovant (IMVT) Reports Narrower-Than-Expected Loss in Q4 - Yahoo Finance
finance.yahoo.com - June 2 at 7:18 PM
SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Immunovant, Inc. (IMVT) and Encourages Stockholders to Contact the FirmSHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Immunovant, Inc. (IMVT) and Encourages Stockholders to Contact the Firm
finance.yahoo.com - June 2 at 2:17 PM
Immunovant (NASDAQ:IMVT) Shares Gap Up on Analyst UpgradeImmunovant (NASDAQ:IMVT) Shares Gap Up on Analyst Upgrade
americanbankingnews.com - June 2 at 1:50 PM
Immunovant Sees Unusually Large Options Volume (NASDAQ:IMVT)Immunovant Sees Unusually Large Options Volume (NASDAQ:IMVT)
americanbankingnews.com - June 2 at 11:28 AM
HC Wainwright Lowers Immunovant (NASDAQ:IMVT) Price Target to $19.00HC Wainwright Lowers Immunovant (NASDAQ:IMVT) Price Target to $19.00
americanbankingnews.com - June 2 at 9:36 AM
Immunovant (NASDAQ:IMVT) Price Target Lowered to $17.00 at SVB LeerinkImmunovant (NASDAQ:IMVT) Price Target Lowered to $17.00 at SVB Leerink
americanbankingnews.com - June 2 at 8:24 AM
Immunovant (NASDAQ:IMVT) PT Lowered to $20.00Immunovant (NASDAQ:IMVT) PT Lowered to $20.00
americanbankingnews.com - June 2 at 8:24 AM
Immunovant (NASDAQ:IMVT) Price Target Raised to $26.00 at Credit Suisse GroupImmunovant (NASDAQ:IMVT) Price Target Raised to $26.00 at Credit Suisse Group
americanbankingnews.com - June 2 at 8:24 AM
Immunovant (NASDAQ:IMVT) Issues Quarterly Earnings Results, Beats Expectations By $0.04 EPSImmunovant (NASDAQ:IMVT) Issues Quarterly Earnings Results, Beats Expectations By $0.04 EPS
americanbankingnews.com - June 2 at 7:14 AM
Immunovant sinks 28% after CMO departs, Stifel cuts shares - Seeking AlphaImmunovant sinks 28% after CMO departs, Stifel cuts shares - Seeking Alpha
seekingalpha.com - June 1 at 11:50 PM
Investors Buy High Volume of Immunovant Call Options (NASDAQ:IMVT)Investors Buy High Volume of Immunovant Call Options (NASDAQ:IMVT)
americanbankingnews.com - June 1 at 8:42 PM
Raymond James Downgrades Immunovant (NASDAQ:IMVT) to Market PerformRaymond James Downgrades Immunovant (NASDAQ:IMVT) to Market Perform
americanbankingnews.com - June 1 at 5:26 PM
Immunovant (NASDAQ:IMVT) Stock Rating Lowered by GuggenheimImmunovant (NASDAQ:IMVT) Stock Rating Lowered by Guggenheim
americanbankingnews.com - June 1 at 3:54 PM
Nuwellis, Aesthetic Medical leads healthcare gainers; Immunovant, Shineco among major losers - Seeking AlphaNuwellis, Aesthetic Medical leads healthcare gainers; Immunovant, Shineco among major losers - Seeking Alpha
seekingalpha.com - June 1 at 1:50 PM
Form 10-K Immunovant, Inc. For: Mar 31 - StreetInsider.comForm 10-K Immunovant, Inc. For: Mar 31 - StreetInsider.com
streetinsider.com - June 1 at 1:50 PM
Immunovant Enters Oversold Territory (IMVT) - NasdaqImmunovant Enters Oversold Territory (IMVT) - Nasdaq
nasdaq.com - June 1 at 1:50 PM
Mid-Day Market Update: Crude Oil Surges 3.5%; Immunovant Shares Plummet - BenzingaMid-Day Market Update: Crude Oil Surges 3.5%; Immunovant Shares Plummet - Benzinga
benzinga.com - June 1 at 1:50 PM
Immunovant (NASDAQ:IMVT) Cut to Hold at Stifel NicolausImmunovant (NASDAQ:IMVT) Cut to Hold at Stifel Nicolaus
americanbankingnews.com - June 1 at 12:26 PM
Immunovant (NASDAQ:IMVT) Reaches New 52-Week Low at $10.22Immunovant (NASDAQ:IMVT) Reaches New 52-Week Low at $10.22
americanbankingnews.com - June 1 at 11:46 AM
Immunovant Provides Corporate Updates and Reports Financial - GlobeNewswireImmunovant Provides Corporate Updates and Reports Financial - GlobeNewswire
globenewswire.com - June 1 at 8:07 AM
Immunovant Provides Corporate Updates and Reports Financial Results for the Quarter and Fiscal Year Ended March 31, 2021Immunovant Provides Corporate Updates and Reports Financial Results for the Quarter and Fiscal Year Ended March 31, 2021
finance.yahoo.com - June 1 at 8:07 AM
First Week of January 2022 Options Trading For Immunovant (IMVT) - NasdaqFirst Week of January 2022 Options Trading For Immunovant (IMVT) - Nasdaq
nasdaq.com - May 23 at 10:33 AM
Roivant Double-SPAC Deal Wallows In Own Cleverness - Seeking AlphaRoivant Double-SPAC Deal Wallows In Own Cleverness - Seeking Alpha
seekingalpha.com - May 21 at 9:09 PM
Money Stuff: You Can SPAC Your SPAC - BloombergMoney Stuff: You Can SPAC Your SPAC - Bloomberg
bloomberg.com - May 19 at 12:56 PM
A SPAC Will Buy Back Its Own SPAC and Pay a Staggering Premium - BloombergA SPAC Will Buy Back Its Own SPAC and Pay a Staggering Premium - Bloomberg
bloomberg.com - May 19 at 12:56 PM
A SPAC Will Buy Back Its Own SPAC and Pay a Staggering PremiumA SPAC Will Buy Back Its Own SPAC and Pay a Staggering Premium
finance.yahoo.com - May 19 at 12:56 PM
Will Biotech Stocks Slide Become a Rout? June Holds the Key. - BarronsWill Biotech Stocks' Slide Become a Rout? June Holds the Key. - Barron's
barrons.com - May 14 at 2:13 PM
Will Biotech Stocks’ Slide Become a Rout? June Holds the Key.Will Biotech Stocks’ Slide Become a Rout? June Holds the Key.
finance.yahoo.com - May 14 at 2:13 PM
Interesting IMVT Put And Call Options For December 17th - NasdaqInteresting IMVT Put And Call Options For December 17th - Nasdaq
nasdaq.com - May 5 at 4:59 PM
Roivant Sciences Gets SPAC Deal: What To Expect From This BioPharma, Health Technology Company - BenzingaRoivant Sciences Gets SPAC Deal: What To Expect From This BioPharma, Health Technology Company - Benzinga
benzinga.com - May 4 at 12:18 AM
INVESTOR DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Immunovant, Inc. and Encourages Investors with Losses to Contact the Firm - Yahoo FinanceINVESTOR DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Immunovant, Inc. and Encourages Investors with Losses to Contact the Firm - Yahoo Finance
finance.yahoo.com - April 21 at 1:15 AM
Last Chance to Actively Participate: Bronstein, Gewirtz & Grossman, LLC Reminds Immunovant, Inc. (IMVT) Investors of Class Action and Lead Plaintiff Deadline: April 20, 2021 - Yahoo FinanceLast Chance to Actively Participate: Bronstein, Gewirtz & Grossman, LLC Reminds Immunovant, Inc. (IMVT) Investors of Class Action and Lead Plaintiff Deadline: April 20, 2021 - Yahoo Finance
finance.yahoo.com - April 20 at 8:14 PM
Last Chance to Actively Participate: Bronstein, Gewirtz & Grossman, LLC Reminds Immunovant, Inc. (IMVT) Investors of Class Action and Lead Plaintiff Deadline: April 20, 2021Last Chance to Actively Participate: Bronstein, Gewirtz & Grossman, LLC Reminds Immunovant, Inc. (IMVT) Investors of Class Action and Lead Plaintiff Deadline: April 20, 2021
finance.yahoo.com - April 20 at 8:14 PM
IMVT Final Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds Immunovant, Inc. Investors of Class Action and Lead Plaintiff Deadline: April 20, 2021 - Yahoo FinanceIMVT Final Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds Immunovant, Inc. Investors of Class Action and Lead Plaintiff Deadline: April 20, 2021 - Yahoo Finance
finance.yahoo.com - April 20 at 3:13 PM
IMVT Final Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds Immunovant, Inc. Investors of Class Action and Lead Plaintiff Deadline: April 20, 2021IMVT Final Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds Immunovant, Inc. Investors of Class Action and Lead Plaintiff Deadline: April 20, 2021
finance.yahoo.com - April 20 at 3:13 PM
INVESTOR DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Immunovant, Inc. and Encourages Investors with Losses to Contact the FirmINVESTOR DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Immunovant, Inc. and Encourages Investors with Losses to Contact the Firm
finance.yahoo.com - April 20 at 3:13 PM
DEADLINE TODAY: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Immunovant, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm - Yahoo FinanceDEADLINE TODAY: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Immunovant, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm - Yahoo Finance
finance.yahoo.com - April 20 at 10:12 AM
DEADLINE TODAY: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Immunovant, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmDEADLINE TODAY: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Immunovant, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
finance.yahoo.com - April 20 at 10:12 AM
SHAREHOLDER DEADLINE TOMORROW: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Immunovant, Inc. and Encourages Investors with Losses to Contact the FirmSHAREHOLDER DEADLINE TOMORROW: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Immunovant, Inc. and Encourages Investors with Losses to Contact the Firm
finance.yahoo.com - April 19 at 5:37 PM
DEADLINE TOMORROW: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Immunovant, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm - Yahoo FinanceDEADLINE TOMORROW: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Immunovant, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm - Yahoo Finance
finance.yahoo.com - April 19 at 12:36 PM
IMVT Deadline Tomorrow: Bronstein, Gewirtz & Grossman, LLC Reminds Immunovant, Inc. Investors of Class Action and Lead Plaintiff Deadline: April 20, 2021 - Yahoo FinanceIMVT Deadline Tomorrow: Bronstein, Gewirtz & Grossman, LLC Reminds Immunovant, Inc. Investors of Class Action and Lead Plaintiff Deadline: April 20, 2021 - Yahoo Finance
finance.yahoo.com - April 19 at 12:36 PM
FINAL DEADLINE IMMINENT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Immunovant, Inc. and Encourages Investors with Losses to Contact the Firm - Yahoo Finance AustraliaFINAL DEADLINE IMMINENT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Immunovant, Inc. and Encourages Investors with Losses to Contact the Firm - Yahoo Finance Australia
finance.yahoo.com - April 19 at 1:03 AM
This page was last updated on 6/18/2021 by MarketBeat.com Staff

As Featured By:

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.